derick raal discusses the safety of very low ldl cholesterol
Published 8 years ago • 341 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
3:26
prof john chapman: physiological implications of very low ldl cholesterol levels
-
1:12
prof. s. nicholls: patient progress despite very low ldl cholesterol levels on a pcsk9 inhibitor
-
3:26
achieving very low ldl-c levels with the pcsk9 inhibitor evolocumab
-
1:22
do the pcsk9 monoclonal antibodies have neurocognitive effects | professor frederick raal
-
0:43
professor stephen nicholls are very low ldl cholesterol levels safe
-
8:17
extremely low ldl cholesterol beneficial in patients with cad | dr. raman puri | emcure csi tv
-
51:18
advanced lipid testing w dr ronald krauss part i
-
6:47
non-hdl-c is a better predictor of cv risk than ldl-c | dr. sn narasingan | emcure csi tv
-
2:48
prof derick raal discusses taussig homozygous fh cohort
-
2:26
rationale for tesla and results | professor derick raal
-
40:21
professor peter libby - professor derick raal - inflammation vs ldl lowering
-
46:28
ldl-c: how low should we go?
-
4:24
repatha: pcsk9 inhibitor use/development & very low ldl levels
-
3:08
prof derick raal late breaking session at eas congress 2019
-
3:31
pcsk9 antibody dramatically lowers ldl
-
1:38
will pcsk9 monoclonal antibodies replace other lipid lowering treatment | professor frederick raal
-
5:03
are pcsk9 inhibitors for ldl cholesterol safe and effective?
-
1:17
why lowest is best for ldl cholesterol
-
26:44
dr erin bohula may - 'at the limits of lipid management – statins to pcsk9 inhibitors'
-
52:04
a real world approach to ldl cholesterol using pcsk9 inhibitors, october 5 2018
-
1:16
overlap between hofh and severe fh and implications for evolocumab | professor frederick raal
-
0:55
pcsk9 function, influence to the ldl-r recycling